There is no question that asbestos is a carcinogen. We know that this material can lead to cancer. What is often debated within the courtroom is responsibility. Who is responsible for the asbestos exposure that led to the cancer? Was it the company that made the product, the employer that used it or did the worker make a mistake that led to exposure?
September 26 may just be another day on the calendar, another day to go about one's business, but it also marks something special. It is a day dedicated to bringing awareness to mesothelioma and the devastating effects it has on those who suffer from it. Sadly, numerous Ohio residents have been diagnosed with this terrible disease over the years, and many more have had to watch their loved ones suffer through and ultimately succumb to it.
The once widespread use of asbestos has left generations at risk for developing a fatal cancer. Every year, around 3,000 people learn that they have this deadly disease called mesothelioma. This is not just a problem of the past, either. Degrading asbestos is a source of new and ongoing exposure in Ohio.
As medical technology continues to grow and advance, researchers in Ohio and across the nation are constantly seeking out new ways to treat serious health conditions. Recent reports of a new type of cancer treatment that helps combat tumors could provide hope to those who are suffering from conditions such as mesothelioma. This new treatment reportedly acts to block a certain protein, which in turn helps immune cells combat tumors and researchers say this could prove helpful in battling conditions that are typically more resistant to immunotherapy, such as mesothelioma.
It does not matter whether the patient is from Ohio or some other state, receiving a cancer diagnosis is devastating. For those who receive a diagnosis of a rare form of cancer called mesothelioma, the aftermath can be even worse since there is no cure and the prognosis is not always a good one. However, some people do come through treatment with the cancer destroyed or removed, but that does not necessarily mean it will not come back.
Medical researchers spend their time searching for cures and treatments for debilitating and deadly illnesses. One of those medical conditions is mesothelioma. Ohio residents who either suffer from this rare form of cancer or fear asbestos exposure could cause them to suffer from it may like to know that ongoing research into treatments continues to show promise.
Researchers continue to explore treatments for rare illnesses in order to extend patients' lives or cure them. One of those illnesses is peritoneal mesothelioma, which has no cure. However, treatments can make individuals suffering from it more comfortable or extend their lives. For instance, some patients here in Ohio and elsewhere may qualify for a surgical procedure called Hyperthermic Intraperitoneal Chemotherapy.
Someone exposed to asbestos could live for decades without any repercussions. Then one day, it all changes. After a visit to the doctor, an Ohio resident could receive the diagnosis they hoped would never come -- mesothelioma. More than likely, the doctor will give him or her data on the survival rates for this rare form of cancer, but the real question is whether those numbers apply to everyone.
It cannot be easy for an Ohio resident to receive news that he or she suffers from an incurable cancer most likely caused by breathing in asbestos while at work several decades ago. Mesothelioma has no cure, but researchers continue to work on treatments that may extend life and arrest further tumor development for some patients suffering from pleural mesothelioma. One such treatment recently completed its second phase of research, and the results are promising.
Most doctors here in Ohio and elsewhere would have no reason to suspect that an individual suffered exposure to asbestos at some point in the past. Even so, this piece of information is vital in order to help explain certain symptoms as they arise, such as a shortness of breath, which could indicate mesothelioma, which is the rare cancer associated with such exposure. However, even knowing this about a patient does not guarantee an easy diagnosis.